Efficacy and safety of novel anticoagulants versus vitamin K antagonists in patients with mild and moderate to severe renal insufficiency: Focus on apixaban.
暂无分享,去创建一个
G. Rosano | C. Gaudio | F. Pelliccia | G. Marazzi | S. Rosanio | C. Greco | S. Poggi | A. Tanzilli